GameStop shares fall for seven consecutive sessions

GameStop (NYSE:GME) shares clocked seven straight sessions of losses on Thursday, as the stock closed 0.04% lower to $22.44.

The games and entertainment products company lost 6.3% in the preceding six sessions. Overall, the stock has lost 28% so far this year, compared to the over 8% rise in the broader S&P 500 Index (SP500).

GME is down 5% over the past one month.

Most recently, Quantum BioPharma (QNTM), a biopharmaceutical company focused on treatments for neurodegenerative disorders, has acquired 2,000 shares of GameStop as a strategic investment to be held on its balance sheet.

Looking at Seeking Alpha’s Quant Rating, GME has a Hold rating with a score of 3.2 out of 5. The company received C+ in the prospect of profitability and a D- in the valuation factor.

Seeking Alpha analysts are also cautious and see the stock as a Hold.

“GME’s aggressive pivot into the trading card market, including PSA partnerships and card grading, is a high-margin, high-growth opportunity being overlooked by the market,” pointed out a recent Seeking Alpha analysis.